What to think if the results of the National Institutes of Health randomized trial of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus control measures are negative (and other advice to young epidemiologists): A review and an Au revoir

Infection Control and Hospital Epidemiology

Volumn 27, Issue 10, 2006, Pages 1096-1106

  Farr, Barry M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; AUSTRALIA; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM DETECTION; CLINICAL TRIAL; DISEASE SURVEILLANCE; HEALTH CARE FACILITY; HEALTH CARE ORGANIZATION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE; LONG TERM CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; NONHUMAN; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME; SMALLPOX; TUBERCULOSIS; UNITED STATES; VANCOMYCIN RESISTANT ENTEROCOCCUS;

CROSS INFECTION; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; METHICILLIN RESISTANCE; RANDOMIZED CONTROLLED TRIALS; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN RESISTANCE;

EID: 33750541275     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/508759     Document Type: Review

References (136)

1. Rilke RM. Letters to a Young Poet. New York: W.W. Norton and Company; 1934.
2. Shakespeare W. The Tempest, Act V, scene I, line ∼43 ff. London, 1611. in Harrison GB, ed. Shakespeare: major plays and sonnets. New York: Harcourt Brace and World; 1984.
3. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-485.
4. Klevens RM, Edwards JR, Tenover FC, McDonald LC, Horan T, Gaynes R; National Nosocomial Infections Surveillance System. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 2006; 42:389-391.
5. Abramson MA, Sexton DJ. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol 1999; 20:408-411.
6. Cheng AF, French GL. Methicillin-resistant Staphylococcus aureus bacteremia in Hong Kong. J Hosp Infect 1988; 12:91-101.
7. Stone PW, Larson E, Kawar LN. A systematic audit or economic evidence linking nosocomial infections and infection control interventions: 1990-2000. Am J Infect Control 2002; 30:145-152.
8. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005; 26:166-174.
9. Reed SD, Friedman JY, Engemann JJ, et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2005; 26:175-183.
10. McHugh CG, Riley LW. Risk factors and costs associated with methicillin-resistant Staphylococcus aureus bloodstream infections. Infect Control Hosp Epidemiol 2004; 25:425-430.
11. Stosor V, Peterson L, Postelnick M, Noskin G. Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med 1998; 158:522-527.
12. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bactermia: a meta-analysis. Clin Infect Dis 2003; 36:53-59.
13. Whitby M, McLaws ML, Berry G. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust 2001; 175:264-267.
14. Salgado CD, Farr BM. Outcomes associated with vancomycin resistant enterococci: a meta-analysis. Infect Control Hosp Epidemiol 2003; 24:690-698.
15. DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 2005; 41:327-333.
16. West TE, Guerry C, Hiott M, Morrow N, Ward K, Salgado CD. Effect of targeted surveillance for control of methicillin-resistant Staphylococcus aureus in a community hospital system. Infect Control Hosp Epidemiol 2006; 27:233-238.
17. Lucet J, Chevret S, Durand-Zaleski I, Chastang Cregnier B. Prevalence and risk factors for carriage of methicillin resistant Staphylococcus aureus at admission to the intensive care unit. Arch Intern Med 2003; 163:181-188.
18. Bjorholt I, Haglind E. Cost-savings achieved by eradication of epidemic methicillin-resistant Staphylococcus aureus (EMRSA)-Io from a large teaching hospital. Eur J Clin Microbiol Infect Dis 2004; 23:688-695.
19. Vriens M, Blok H, Fluit A, Troelstra A, van der WC, Verhoef J. Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: a 10-year survey. Eur J Clin Microbiol Infect Dis 2002; 21:782-786.
20. Karchmer TB, Durbin LJ, Simonton BM, Farr BM. Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2002; 51:126-132.
21. Papia G, Louie M, Tralla A, Johnson C, Collins V, Simor AE. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective? Infect Control Hosp Epidemiol 1999; 20:473-477.
22. Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999; 282:1745-1751.
23. Jernigan JA, Clemence MA, Stott GA, et al. Control of methicillin resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol 1995; 16:686-696.
24. Muto CA, Giannetta ET, Durbin LJ, Simonton BM, Farr BM. Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2002; 23:429-435.
25. Montecalvo MA, Jarvis WR, Uman J, et al. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting. Infect Control Hosp Epidemiol 2001; 22:437-442.
26. Bronstein M, Kaye K, Sexton D. Gown utilization as a measure of cost of methicillin-resistant Staphylococcus aureus (MRSA) screening. In: Program and abstracts of the 12th Annual Meeting of the Society for Healthcare Epidemiology of America; April 6-9, 2002; Salt Lake City, UT. Abstract 47.
27. Calfee DP, Farr BM. Infection control and cost control in the era of managed care. Infect Control Hosp Epidemiol 2002; 23:407-410.
28. Strausbaugh LJ, Siegel JD, Weinstein RA. Preventing transmission of multidrug-resistant bacteria in health care settings: a tale of 2 guidelines. Clin Infect Dis 2006; 42:828-835.
29. Salgado CD, Farr BM. The importance of infection control in controlling antimicrobial-resistant pathogens. In: Jarvis WR, ed. Bennett and Brachman's Hospital Infections. 5th ed. Philadelphia: Lippincott Williams & Wilkins (in press).
30. Wertheim HF, Vos MC, Boelens HA, et al. Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in The Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect 2004; 56:321-325.
31. Kotilainen P, Routamaa M, Peltonen R, et al. Elimination of epidemic methicillin-resistant Staphylococcus aureus from a university hospital and district institutions, Finland. Emerg Infect Dis 2003; 9:169-175.
32. Peterson L. Lessons to be shared in successful reductions of infections. Illinois Quality Leadership Conference- Focusing on Reducing and Eliminating Infections. Naperville, IL: Illinois Hospital Association and Metropolitan Chicago Healthcare Council; May 24, 2006.
33. Verbrugh HA. Best practices from The Netherlands. In: Program and abstracts of the 2nd Infection Prevention and Control Conference: Managing MRSA-a call to action. Co-convened by the Association for Professionals in Infection Control and Epidemiology, and Joint Commission Resources. August 15, 2006; Cambridge, MA.
34. Cooper BS, Stone SP, Kibbler CC, et al. Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. BMJ 2004; 329:533-538.
35. Cepeda JA, Whitehouse T, Cooper B, et al. Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet 2005; 365:295-304.
36. Frost WH. Epidemiology. In Maxcy KF, ed. The Papers of Wade Hampton Frost, M.D. New York, NY: The Commonwealth Fund; 1941:493-542.
37. Shakespeare W. Richard II, Act II, scene I, line ∼43, ff., London; 1594.
38. Panum PL. Observations Made During the Epidemic of Measles on the Faroe Islands in the Year 1846. New York: American Public Health Association; 1940.
39. McKay N, Wallis L. Rabies: a review of UK management. Emerg Med J 2005; 22:316-321.
40. Paul JH, Freese HL. Epidemiological and bacteriological study of "common cold" in isolated Arctic community (Spitsbergen). Am J Hygiene 1933; 17:517-535.
41. Tiemersma EW, Monnet DL, Bruinsma N, Skov R, Monen JC, Grundmann H. Staphylococcus aureus bacteremia, Europe. Emerg Infect Dis 2005; 11:1798-1799.
42. Tiemersma EW, Bronzwaer SL, Lyytikainen O, et al.; European Antimicrobial Resistance Surveillance System Participants. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004; 10:1627-1634.
43. Verhoef J, Beaujean D, Blok H, et al. A Dutch approach to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1999; 18:461-466.
44. Salmenlinna S, Lyytikainen O, Kotilainen P, Scotford R, Siren E, Vuopio-Varkila J. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Finland. Eur J Clin Microbiol Infect Dis 2000; 19:101-107.
45. Boyce JM, Cookson B, Christiansen K, et al. Meticillin-resistant Staphylococcus aureus. Lancet Infect Dis 2005; 5:653-663.
46. Dailey L, Coombs GW, O'Brien FG, et al. Methicillin-resistant Staphylococcus aureus, Western Australia. Emerg Infect Dis 2005; 11:1584-1590.
47. Muto CA, Jernigan JA, Ostrowksy BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003; 24:362-386.
48. Herrera O, Rhoton B, Cantey J. Control of methicillin-resistant Staphylococcus aureus (MRSA) in a neonatal intensive care unit using active surveillance: one year follow-up. In: Program and abstracts of the 13th Annual Meeting of the Society for Healthcare Epidemiology of America; April 5-8, 2003, Arlington, VA. Abstract 92.
49. Arnow P, Allyn PA, Nichols EM, Hill DL, Pezzlo M, Bartlett RH. Control of methicillin-resistant Staphylococcus aureus in a burn unit: role of nurse staffing. J Trauma 1982; 22:954-959.
50. Blumberg LH, Klugman KP. Control of methicillin-resistant Staphylococcus aureus bacteraemia in high-risk areas. Eur J Clin Microbiol Infect Dis 1994; 13:82-85.
51. Campbell JR, Zaccaria E, Mason EO Jr, Baker CJ. Epidemiological analysis defining concurrent outbreaks of Serratia marcescens and methicillin-resistant Staphylococcus aureus in a neonatal intensive-care unit. Infect Control Hosp Epidemiol 1998; 19:924-928.
52. Coello R, Jimenez J, Garcia M, et al. Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur J Clin Microbiol Infect Dis 1994; 13:74-81.
53. Cosseron-Zerbib M, Roque Afonso AM, Naas T, et al. A control programme for MRSA (methicillin-resistant Staphylococcus aureus) containment in a paediatric intensive care unit: evaluation and impact on infections caused by other micro-organisms. J Hosp Infect 1998; 40:225-235.
54. Cox RA, Conquest C, Mallaghan C, Marples RR. A major outbreak of methicillin-resistant Staphylococcus aureus caused by a new phage-type (EMRSA-16). J Hosp Infect 1995; 29:87-106.
55. Duckworth GJ, Lothian JL, Williams JD. Methicillin-resistant Staphylococcus aureus: report of an outbreak in a London teaching hospital. J Hosp Infect 1988; 11:1-15.
56. Girou E, Pujade G, Legrand P, Cizeau F, Brun-Buisson C. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 1998; 27:543-550.
57. Pfaller MA, Wakefield DS, Hollis R, Frederickson M, Evans E, Massanari RM. The clinical microbiology laboratory as an aid in infection control: the application of molecular techniques in epidemiologic studies of methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis 1991; 14:209-217.
58. Linnemann CC Jr, Mason M, Moore P, Korfhagen TR, Staneck IL. Methicillin-resistant Staphylococcus aureus: experience in a general hospital over four years. Am J Epidemiol 1982; 115:941-950.
59. Walsh TJ, Vlahov D, Hansen SL, et al. Prospective microbiologic surveillance in control of nosocomial methicillin-resistant Staphylococcus aureus. Infect Control 1987; 8:7-14.
60. Wernitz MH, Swidsinski S, Weist K, et al. Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to prevent hospital-acquired MRSA infections. Clin Microbiol Infect 2005; 11:457-465.
61. Huang SS, Yokoe DS, Rego VH, et al. Impact of ICU surveillance for MRSA on bacteremia. In: Program and abstracts of the 43rd Annual Meeting of the Infectious Diseases Society of America; October 6-9, 2005; San Francisco, CA. Abstract 1074.
62. Blank MK, Haas L, Donahoe M, Kramer P, Muto CA. Sustained effect in reducing methicillin-resistant Staphylococcus aureus (MRSA) hospital acquired infections (HAIs) using active MRSA surveillance cultures (MSC)-three-year follow-up. In: Program and abstracts of the 15th Annual Meeting of the Society for Healthcare Epidemiology of America; 2005; Los Angeles, California. Abstract 22.
63. Mishal J, Sherer Y, Levin Y, Katz D, Embon E. Two-stage evaluation and intervention program for control of methicillin-resistant Staphylococcus aureus in the hospital setting. Scand J Infect Dis 2001; 33:498-501.
64. Talon D, Vichard P, Muller A, Bertin M, Jeunet L, Bertrand X. Modelling the usefulness of a dedicated cohort facility to prevent the dissemination of MRSA. J Hosp Infect 2003; 54:57-62.
65. Rao N, Jacobs S, Joyce L. Cost-effective eradication of an outbreak of methicillin-resistant Staphylococcus aureus in a community teaching hospital. Infect Control Hosp Epidemiol 1988; 9:255-260.
66. Pan A, Carnevale G, Catenazzi P, et al. Trends in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: effect of the MRSA "search and isolate" strategy in a hospital in Italy with hyperendemic MRSA. Infect Control Hosp Epidemiol 2005; 26:127-133.
67. Harberg D. Society for Healthcare Epidemiology of America guideline approach works to control a methicillin-resistant Staphylococcus aureus outbreak. Infect Control Hosp Epidemiol 2005; 26:115-116.
68. Khoury J, Jones M, Grim A, Dunne WM Jr, Fraser V. Eradication of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit by active surveillance and aggressive infection control measures. Infect Control Hosp Epidemiol 2005; 26:616-621.
69. Saiman L, Cronquist A, Wu F, et al. An outbreak of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2003; 24:317-321.
70. Boyce JM, Havill NL, Kohan C, Dumigan DG, Ligi CE. Do infection control measures work for methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 2004; 25:395-401.
71. Tomic V, Svetina Sorli P, Trinkaus D, Sorli J, Widmer AF, Trampuz A. Comprehensive strategy to prevent nosocomial spread of methicillin-resistant Staphylococcus aureus in a highly endemic setting. Arch Intern Med 2004; 164:2038-2043.
72. Sax H, Posfay-Barbe K, Harbarth S, et al. Control of a cluster of community-associated, methicillin-resistant Staphylococcus aureus in neonatology. J Hosp Infect 2006; 63:93-100.
73. Lucet JC, Paoletti X, Lolom I, Paugam-Burtz C, et al. Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med 2005; 31:1051-1057.
74. Farrington M, Redpath C, Trundle C, Coomber S, Brown NM. Winning the battle but losing the war: methicillin-resistant Staphylococcus aureus (MRSA) infection at a teaching hospital. QJM 1998; 91:539-548.
75. Boyce JM, Mermel LA, Zervos MJ, et al. Controlling vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1995; 16:634-637.
76. Boyce JM, Opal SM, Chow JW, et al. Outbreak of multi-drug resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994; 32:1148-1153.
77. Livornese LL, Dias S, Romanowski B, Taylor S, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992; 117:112-116.
78. Byers KE, Anglim AM, Anneski CJ, et al. A hospital epidemic of vancomycin-resistant enterococcus: risk factors and control. Infect Control Hosp Epidemiol 2001; 22:140-147.
79. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 2001; 344:1427-1433.
80. Price CS, Paule S, Noskin GA, Peterson LR. Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia. Clin Infect Dis 2003; 37:921-928.
81. Siddiqui AH, Harris AD, Hebden J, Wilson PD, Morris JG, Roghmann M. The effect of active surveillance for vancomycin resistant enterococci in high risk units on vancomycin resistant enterococci incidence hospital-wide. Am J Infect Control 2002; 30:40-43.
82. Muto CA, Posey K, Blank M, et al. Controlling vancomycin resistant enterococci (VRE) using weekly surveillance culturing (VRESC) and barrier precautions (BP): "search and destroy." In: Program and abstracts of the 14th Annual Meeting of the Society for Healthcare Epidemiology of America; April 17-20, 2004; Philadelphia, PA. Abstract 365.
83. Christiansen KJ, Tibbett PA, Beresford W, et al. Eradication of a large outbreak of a single strain of vanB vancomycin-resistant Enterococcus faecium at a major Australian teaching hospital. Infect Control Hosp Epidemiol 2004; 25:384-390.
84. Mascini EM, Troelstra A, Beitsma M, et al. Genotyping and preemptive isolation to control an outbreak of vancomycin-resistant Enterococcus faecium. Clin Infect Dis 2006; 42:739-746.
85. Seeberg S, Larsson L, Welinder-Olsson C, et al. How an outbreak of MRSA in Gothenburg was eliminated: by strict hygienic routines and massive control-culture program [in German] Lakartidningen 2002; 99:3198-3204.
86. Vriens MR, Fluit AC, Troelstra A, Verhoef J, Van Der Werken C. Are MRSA more contagious than MSSA in a surgical intensive care unit. Infect Control Hosp Epidemiol 2002; 23:491-494.
87. Esveld MI, de Boer AS, Notenboom AJ, van Pelt W, van Leeuwen WJ. Secondary infection with methicillin resistant Staphylococcus aureus in Dutch hospitals (July 1994-June 1996) [in Dutch]. Nederlands Tijdschrift voor Geneeskunde 1999; 143:205-208.
88. Hill AB. A Short Textbook of Medical Statistics. Vol 11. London: Hodder and Stoughton, 1984.
89. Jernigan JA, Titus MG, Groschel DHM, Getchell-White SI, Farr BM. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 1996; 143:496-504.
90. Bager F. DANMAP 98-Consumption of antimicrobial agents and occurrence of antimicrobials in bacteria from food animals, food and humans in Denmark. 1999. Available at: http://www.danmap.org. Accessed September 10, 2006.
91. Sommer A. SARS: paradigm for an emerging pathogen in a global community. Paper presented at the 14th Annual Meeting of the Society for Healthcare Epidemiology of America; April 17-20, 2004; Philadelphia, PA.
92. Seto WH, Tsang D, Yung RW, et al.; Advisors of Expert SARS group of Hospital Authority. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 2003; 361:1519-1520.
93. Lipsitch M, Cohen T, Cooper B, et al. Transmission dynamics and control of severe acute respiratory syndrome. Science 2003; 300:1966-1970.
94. Beck-Sague CM, Dooley SW, et al. Outbreak of multidrug-resistant tuberculosis among persons with HIV infection in an urban hospital: transmission to staff and patients and control measures. JAMA 1992; 268:1280-1286.
95. Thompson RL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982; 97:309-317.
96. Perencevich EN, Fisman DN, Lipsitch M, Harris AD, Morris JG, Smith D. Projected benefits of active surveillance for vancomycin resistant enterococci in ICU settings. Clin Infect Dis 2004; 38:1108-1115.
97. Netto dos Santos KR, de Souza FL, Gontijo Filho PP. Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from Brazilian university hospitals. Infect Control Hosp Epidemiol 1996; 17:813-816.
98. Miller MA, Dascal A, Portnoy J, Mendelson J. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 1996; 17:811-813.
99. Vasquez JE, Walker ES, Franzus BW, Overbay BK, Reagan DR, Sarubbi FA. The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a Veterans' Affairs hospital. Infect Control Hosp Epidemiol 2000; 21:459-464.
100. Goldmann D. System failure versus personal accountability-the case for clean hands. N Engl J Med 2006; 355:121-123.
101. Harbarth S, Masuet-Aumatell C, Schrenzel J, et al. Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study. Crit Care 2006; 10:R25.
102. Farr BM. The state of the science. Am J Infect Control 2004; 32:106-113.
103. Faoagali JL, Thong ML, Grant D. Ten years' experience with methicillin-resistant Staphylococcus aureus in a large Australian hospital. J Hosp Infect 1992; 20:113-119.
104. Salgado CD, Farr BM. What proportion of hospital patients colonized with methicillin-resistant Staphylococcus aureus are identified by clinical microbiology cultures? Infect Control Hosp Epidemiol 2006; 27:116-121.
105. Back NA, Linnemann CC Jr, Staneck JL, Kotagal UR. Control of methicillin-resistant Staphylococcus aureus in a neonatal intensive-care unit: use of intensive microbiologic surveillance and mupirocin. Infect Control Hosp Epidemiol 1996; 17:227-231.
106. Fekety FF. The epidemiology and prevention of staphylococcal infection. Medicine 1964; 43:593-613.
107. Huang YC, Su LH, Wu TL, Lin TY. Molecular surveillance of clinical methicillin-resistant Staphylococcus aureus isolates in neonatal intensive care units. Infect Control Hosp Epidemiol 2005; 26:157-160.
108. Haley RW, Cushion NB, Tenover FC, et al. Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis 1995; 171:614-624.
109. Gerber SI, Jones RC, Scott MV, et al. Management of outbreaks of methicillin-resistant Staphylococcus aureus infection in the neonatal intensive care unit: a consensus statement. Infect Control Hosp Epidemiol 2006; 27:139-145.
110. Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. British Society for Antimicrobial Chemotherapy, Hospital Infection Society and the Infection Control Nurses Association. J Hosp Infect 1998; 39:253-290.
111. Wilson APR, Bellingan G, Singer M. Isolation of patients with MRSA infection. Lancet 2005; 365:1304-1305.
112. Poutanen SM, Vearncombe M, McGeer AJ, Gardam M, Large G, Simor AE. Nosocomial acquisition of methicillin-resistant Staphylococcus aureus during an outbreak of severe acute respiratory syndrome. Infect Control Hosp Epidemiol 2005; 26:134-137.
113. Maki DG, McCormick RD, Zilz MA, Stolz SM, Alvarado CJ. An MRSA outbreak in a SICU during universal precautions: new epidemiology for nosocomial MRSA; downside for universal precautions. In: Program and abstracts of the 3rd Decennial International Conference on Nosocomial Infections. Atlanta: Centers for Disease Control and Prevention; 1990:26.
114. Yap FH, Gomersall CD, Fung KS, et al. Increase in methicillin-resistant Staphylococcus aureus acquisition rate and change in pathogen pattern associated with an outbreak of severe acute respiratory syndrome. Clin Infect Dis 2004; 39:511-516.
115. Sherertz RJ, Reagan DR, Hampton KD, et al. A cloud adult: the Staphylococcus aureus-virus interaction revisited. Ann Intern Med 1996; 124:539-547.
116. Suh HK, Jeon YH, Song JS, Hwang SJ, Cheong HJ. A molecular epidemiologic study of methicillin-resistant Staphylococcus aureus infection in patients undergoing middle ear surgery. Eur Arch Oto-Rhino-Laryngol 1998; 255:347-351.
117. Blok HE, Troelstra A, Kamp-Hopmans TE, et al. Role of healthcare workers in outbreaks of methicillin-resistant Staphylococcus aureus: a 10-year evaluation from a Dutch university hospital. Infect Control Hosp Epidemiol 2003; 24:679-185.
118. Salgado C, Nobels D, Ruisz M, et al. Control of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) using active surveillance cultures and contact precautions. In: Program and abstracts of the 14th Annual Meeting of the Society for Healthcare Epidemiology of America; April 17-20, 2004; Philadelphia, PA. Abstract 41.
119. Salgado CD, Nobels D, Ruisz M, et al. Effect of active surveillance cultures and contact precautions for controlling endemic vancomycin-resistant Enterococcus. In: Program and abstracts of the 14th Annual Meeting of the Society for Healthcare Epidemiology of America; April 17-20, 2004; Philadelphia, PA. Abstract 364.
120. Nijssen S, Bonten MJ, Weinstein RA. Are active microbiological surveillance and subsequent isolation needed to prevent the spread of methicillin-resistant Staphylococcus aureus?. Clin Infect Dis 2005; 40:405-409.
121. Marshall C, Harrington G, Wolfe R, Fairley CK, Wesselingh S, Spelman D. Acquisition of methicillin-resistant Staphylococcus aureus in a large intensive care unit. Infect Control Hosp Epidemiol 2003; 24:322-326.
122. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of methicillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006; 368:874-885.
123. Stelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection control. JAMA 2003; 290:1899-1905.
124. ClinicalTrials.gov. Hand hygiene: strategies to reduce transmission of antimicrobial resistant bacteria in intensive care units. Available at: http: //clinicaltrials.gov/ct/show/NCT00100386?order=1. Accessed April 13, 2006.
125. Siegel J, Strausbaugh L, Jackson M, Rhinehart E, Chiarello L, Healthcare Practices Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention. Draft guideline for isolation precautions: preventing transmission of infectious agents in Healthcare settings. June, 2004. Available at: http://www.premieruic.com/all/safety/resources/guidelines/cdc_guidelines. jsp. Accessed September 11, 2005.
126. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. New Engl J Med 2000; 342:1887-92.
127. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. New Engl J Med 2000; 342:1878-1886.
128. Last JM. A dictionary of edpidemiology. 2nd ed. Oxford: Oxford University Press; 1988.
129. Eby GA, Davis DR, Halcomb WW. Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study. Antimicrob Agents Chemother 1984; 25:20-24.
130. Karlowski TR, Chalmers TC, Frenkel LD, Kapikian AZ, Lewis TL, Lynch JM. Ascorbic acid for the common cold: a prophylactic and therapeutic trial. JAMA 1975; 231:1038-1042.
131. Farr BM, Gwaltney JM Jr. The problems of taste in placebo matching: zinc gluconate for the common cold. J Chronic Dis 1987; 40:875-879.
132. Farr BM, Conner EM, Betts RF, Oleske J, Minnefor A, Gwaltney JM Jr. Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. Antimicrob Agents Chemother 1987; 31:1183-1187.
133. da Silva Coimbra MV, Silva-Carvalho MC, Wisplinghoff H, et al. Clonal spread of methicillin-resistant Staphylococcus aureus in a large geographic area of the United States. J Hosp Infect 2003; 53:103-110.
134. Morris JG, Shay DK, Hebden JN, et al. Enterococci resistant to multiple antimicrobial agents including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med 1995; 123:250-259.
135. Slaughter S, Hayden MK, Nathan C, et al. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 1996; 125:448-456.
136. Warren DK, Kollef MH, Seiler SM, Fridkin SK, Fraser VJ. The epidemiology of vancomycin-resistant Enterococcus colonization in a medical intensive care unit. Infect Control Hosp Epidemiol 2003; 24:257-263.